Extended Data Fig. 5: The changes of the cytokine and marker of inflammation and coagulopathy in serums obtained from the patients. | Nature Cancer

Extended Data Fig. 5: The changes of the cytokine and marker of inflammation and coagulopathy in serums obtained from the patients.

From: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

Extended Data Fig. 5

a, Serum kinetics of cytokines of eotaxin, IL-18, IL-1RA, IL-7, IP-10, MCP-1, MIP1α, MIP1β, RANTES, and SDF-1ɑ in 8 patients who received infusions with CAR-NK cells. b, Heatmap of a panel of other cytokines detected in the serum from 8 patients at pre- or post-infusion of CAR-NK cells. c, Serum levels of CRP, LDH, Fibrinogen, D-dimer, and Ferritin in 8 patients before and after CAR-NK cell infusion.

Source data

Back to article page